Biotechnology T-cell immunotherapy developer Atara Biotherapeutics has entered into a long-term strategic agreement with Fujifilm Diosynth Biotechnologies (FDB), a subsidiary of FUJIFILM Corporation (Fujifilm) under which Fujifilm will acquire Atara’s T-Cell operations and manufacturing (ATOM) facility in Thousand Oaks, California for $100 million upfront, retaining current manufacturing and quality staff at the site. 27 January 2022